🔗 Share this article

A shadow market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to message these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with numerous of members share comparison images, injection guides and claims of rapid UK delivery. Sellers market the drug there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Several professionals stated the demand for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or prison.

Platform Response and Material Removal

According to TikTok, the platform has taken down problematic material and prohibited associated hashtags and search suggestions. The organization said it was committed to keeping the service secure and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Research also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with photos of slimming results, positive testimonials and detailed instructions for preparing or injecting at home.

Within minutes of entering one community, a seller posted contact information, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Item Information and Costs

Inside these communities, messages display dark colored packages with postal service stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how long a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service stated it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they can’t verify. Although the research behind this drug is valid, these online products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered individuals injured by self-injection from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to possibly significant health risks”.